Navigation Links
Neuralstem's ALS Trial on Clinical Hold
Date:2/20/2009

l the differentiation of these cells into mature, physiologically relevant human neurons and glia. Major Central Nervous System diseases targeted by the Company with research programs currently underway include: Ischemic Spastic Paraplegia, Traumatic Spinal Cord Injury, Huntington's disease and Amyotrophic Lateral Sclerosis (ALS).

In pre-clinical work, the company's cells have extended the life of rats with ALS (Lou Gehrig's disease) as reported the journal TRANSPLANTATION, in collaboration with Johns Hopkins University researchers, and also reversed paralysis in rats with Ischemic Spastic Paraplegia, as reported in NEUROSCIENCE on June 29, 2007, in collaboration with researchers at University of California San Diego.

Cautionary Statement Regarding Forward Looking Information

This news release may contain forward-looking statements made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements in this press release regarding potential applications of Neuralstem's technologies constitute forward-looking statements that involve risks and uncertainties, including, without limitation, risks inherent in the development and commercialization of potential products, uncertainty of clinical trial results or regulatory approvals or clearances, need for future capital, dependence upon collaborators and maintenance of our intellectual property rights. Actual results may differ materially from the results anticipated in these forward- looking statements. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in Neuralstem's periodic reports, including the annual report on Form 10- KSB for the year ended December 31, 2007 and the quarterly report on form 10-Q for the period ended September 30, 2008.


'/>"/>
SOURCE Neuralstem, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... , July 30, 2014 Silicon Valley Bank, ... a study today that examines the merger, acquisition ... device companies.  According to the annual report based on ... potential returns since SVB started tracking the data in ... IPO.  Built on solid healthcare M&A activity over the ...
(Date:7/30/2014)... NEW YORK , July 30, 2014 ... products for oncology supportive care, announced that its novel ... featured in an article on OncLive.com titled, "Study Finds ... Neck Cancers."  Dr. Steve Sonis , a leading ... demand seen in the oncology community for evidence-based strategies ...
(Date:7/30/2014)...   Medical Equipment Solutions, Corp. are pleased ... of Defense (US Army) contract valued at over $2 ... diagnostic machine and technical support staffing. As an 8-A ... Business Administration (SBA), Medical Equipment is proud to support ... medical diagnostic equipment. The SBA 8-A certification is a ...
Breaking Medicine Technology:Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 2Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 3Access Pharmaceuticals Featured On OncLive.com 2Access Pharmaceuticals Featured On OncLive.com 3Medical Equipment Solutions Corp. Awarded $2 Million contract To Service DoD 2
... , Feb. 10 CORD:USE Cord Blood Bank ... System, the fifth-largest public healthcare system in the nation, to ... global registry for patients in need of a potentially life-saving ... will allow CORD:USE to continue building the National Cord Blood ...
... , , ... Cell-Teva Joint Venture,(JV) announced today that the Data Monitoring Committee (DMC) ... of StemEx (called ExCell) and has recommended that the JV,continue to ... take place during Q2 2010. StemEx is being evaluated as a,therapeutic ...
Cached Medicine Technology:CORD:USE Cord Blood Bank Announces Partnership with Memorial Healthcare System 2Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma 2Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma 3
(Date:7/30/2014)... the children at Father’s Home come from different backgrounds ... to mar their respective psychosocial development. There appears to ... has underpinnings in a healthy adolescence and in this ... foreseeable future, would assist in developing the youth. , ... of Foundation members in that remote location – as ...
(Date:7/30/2014)... Kathleen Doheny HealthDay ... Dieting at a young age might set the stage for ... Surveys of college-age women conducted from 1982 to 2012 ... and alcohol abuse. "The younger a woman was when ... [later] to use extreme weight control behaviors -- like vomiting ...
(Date:7/30/2014)... Dennis Thompson HealthDay Reporter ... fruits and vegetables are vital to good health and a ... hit five servings of fruits and vegetables each day, additional ... review suggests. The human body may only be able ... every day, limiting its ability to absorb important nutrients from ...
(Date:7/30/2014)... (USP) have identified an RNA known as INXS that, ... protein, modulates the action of an important gene in ... , According to Sergio Verjovski-Almeida, professor at the USP ... So Paulo Research Foundation (FAPESP), INXS expression is generally ... of stimulating the production of this non-coding RNA can ...
(Date:7/30/2014)... Florida A&M University ( FAMU ) ... professor Ngozi Ugochukwu, Ph.D., will head to Nigeria ... The prestigious Fulbright Scholars Program is a highly ... to students, faculty or professionals who wish to ... and Ugochukwu will conduct respective research on the ...
Breaking Medicine News(10 mins):Health News:The Edusei Foundation Donates Food and Assorted Items to the Fathers’ Home Care Ministries in Takoradi, Ghana 2Health News:Dieting at Young Age Often Backfires, Study Says 2Health News:Dieting at Young Age Often Backfires, Study Says 3Health News:Fruits, Veggies May Have Their Limits in Boosting Lifespan 2Health News:Fruits, Veggies May Have Their Limits in Boosting Lifespan 3Health News:Brazilian researchers identify RNA that regulates cell death 2Health News:Brazilian researchers identify RNA that regulates cell death 3Health News:FAMU Professor and Engineering Student Named Fulbright Scholars 2Health News:FAMU Professor and Engineering Student Named Fulbright Scholars 3
... useless, the appendix now appears to have a reason to ... living in the human gut. , Drawing upon a series ... that the beneficial bacteria in the appendix that aid digestion ... the intestines and emerge afterwards to repopulate the gut. Their ...
... insights into chronic, illnesses, including heart failure and COPD, from ... ... Calif., Oct. 8 VivoMetrics announced today,that noted researcher Bruce D. Johnson, ... LifeShirt(R) System to,the South Pole to collect valuable data for his ongoing ...
... Prescription Pads with ... Enhanced Patient Features, HASBROUCK ... prescription pads, today announced that,it has appointed Richard Zwickel to ... model. Being launched this,month at the PDMA Sharing Conference in ...
... mothers who survived ... breast cancer, ALPHARETTA, Ga., ... brand, celebrates the "Power of Pink" by,announcing the winners of its "Pink ... women will be recognized,during the Susan G. Komen for the Cure Pink ...
... scrapes and bruises, study found , MONDAY, Oct. 8 (HealthDay ... as a non-lethal way to incapacitate suspects, are generally safe ... say U.S. researchers who reviewed almost 1,000 incidents involving the ... to a Taser had mild injuries (such as scrapes and ...
... to More Than Half the Population of Singapore to Use ... ... Facilities -, BOCA RATON, Fla., ... today announced,that SingHealth, the largest healthcare provider in Singapore, has selected,Eclipsys ...
Cached Medicine News:Health News:Appendix isn't useless at all: It's a safe house for bacteria 2Health News:Appendix isn't useless at all: It's a safe house for bacteria 3Health News:VivoMetrics' LifeShirt Going to South Pole to Uncover Clues to High-Altitude Illness 2Health News:VivoMetrics' LifeShirt Going to South Pole to Uncover Clues to High-Altitude Illness 3Health News:Medi-Promotions Hires Industry Executive to Expand its Medi-Scripts Prescription Pad Model 2Health News:'Pink Power Moms' Unite in Atlanta for Day of Pampering and Recognition 2Health News:'Pink Power Moms' Unite in Atlanta for Day of Pampering and Recognition 3Health News:'Pink Power Moms' Unite in Atlanta for Day of Pampering and Recognition 4Health News:Serious Injury Rare With Police Tasers 2Health News:SingHealth Selects Eclipsys Solutions to Help Improve Clinical Outcomes, First Sunrise Clinical Manager Client Outside of North America 2Health News:SingHealth Selects Eclipsys Solutions to Help Improve Clinical Outcomes, First Sunrise Clinical Manager Client Outside of North America 3
This versatile convex array abdominal transducer is multi-frequency, offering 5 levels of fundamental frequencies in addition to 4 settings of Harmonic frequencies. This transducer provides superb im...
HST, versatile convex array abdominal transducer is multi-frequency, offering 5 levels of fundamental frequencies in addition to 4 settings of Harmonic frequencies. This transducer provides superb im...
... is ALOKAs answer to the ... Super High Density, versatile convex ... offering 5 levels of fundamental ... settings of Harmonic frequencies. This ...
The versatility of multiple imaging frequencies and a smaller transducer face make this transducer is perfect for intercostal imaging....
Medicine Products: